Mezagitamab, Mezagitamab placebo-matching injection administered SC
TAK-079-3001
Phase 3 small_molecule active
Quick answer
Mezagitamab, Mezagitamab placebo-matching injection administered SC for IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease) is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active